BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6413740)

  • 21. Urinary acid glycosaminoglycans in a patient with oculo-cerebro-renal syndrome.
    Hayashi S; Nagata T; Kimura A; Tsurumi K
    Tohoku J Exp Med; 1978 Nov; 126(3):225-34. PubMed ID: 734647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the possible role of glycosaminoglycans as natural inhibitors of calcium oxalate stones.
    Sallis JD; Lumley MF
    Invest Urol; 1979 Jan; 16(4):296-9. PubMed ID: 429124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary sulfated glycosaminoglycan insufficiency and chondroitin sulfate supplement in urolithiasis.
    Dissayabutra T; Kalpongnukul N; Chindaphan K; Srisa-Art M; Ungjaroenwathana W; Kaewwongse M; Iampenkhae K; Tosukhowong P
    PLoS One; 2019; 14(3):e0213180. PubMed ID: 30845174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Keratan and herparan sulfaturia: glucosamine-6-sulfate deficiency.
    Matalon R; Wappner R; Deanching M; Brandt IK; Horwitz A
    Ann Clin Lab Sci; 1982; 12(3):234-8. PubMed ID: 6212020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of glycosaminoglycans in urine from patients with nephrotic syndrome and control subjects, and their effects on lipoprotein lipase.
    Staprans I; Garon SJ; Hopper J; Felts JM
    Biochim Biophys Acta; 1981 Dec; 678(3):414-22. PubMed ID: 6459128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of glycosaminoglycans composition in the urine of children in reference to the clinical picture of mucopolysaccharidoses.
    Gadowska M; Dawydzik B
    Mater Med Pol; 1983; 15(1-2):24-30. PubMed ID: 6443627
    [No Abstract]   [Full Text] [Related]  

  • 27. Isolation, identification, and quantitation of urinary glycosaminoglycans.
    Lee EY; Kim SH; Whang SK; Hwang KY; Yang JO; Hong SY
    Am J Nephrol; 2003; 23(3):152-7. PubMed ID: 12646785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in cat urinary glycosaminoglycans with age and in feline urologic syndrome.
    Pereira DA; Aguiar JA; Hagiwara MK; Michelacci YM
    Biochim Biophys Acta; 2004 Apr; 1672(1):1-11. PubMed ID: 15056487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Glycosaminoglucuronates and their fractions in the urine of patients with scleroderma].
    Kowalczyk J; Oszewska Z
    Przegl Dermatol; 1978; 65(5):527-33. PubMed ID: 725096
    [No Abstract]   [Full Text] [Related]  

  • 30. Urinary chondroitin sulfates, heparan sulfate and total sulfated glycosaminoglycans in interstitial cystitis.
    Erickson DR; Ordille S; Martin A; Bhavanandan VP
    J Urol; 1997 Jan; 157(1):61-4. PubMed ID: 8976216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzymatic determination of urinary glycosaminoglycans from orthopedic patients.
    Satake S; Ototani N; Isemura M; Yosizawa Z
    Tohoku J Exp Med; 1983 May; 140(1):89-96. PubMed ID: 6408765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of urinary stone disease and extracorporeal shockwave lithotripsy on excretion of glycosaminoglycans.
    Erkurt B; Ilker Y; Budak Y; Ozveren B; Türkeri L; Akdas A
    J Endourol; 1999 Oct; 13(8):553-7. PubMed ID: 10597124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compositional changes of urinary acidic glycosaminoglycans in progressive systemic sclerosis.
    Murata K; Takeda M
    Clin Chim Acta; 1980 Nov; 108(1):49-59. PubMed ID: 6778637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uric acid and its relationship with glycosaminoglycans in normal and stone-former subjects.
    Conte A; Roca P; Genestar C; Grases F
    Nephron; 1989; 52(2):162-5. PubMed ID: 2500615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased urinary excretion of acid mucopolysaccharides and glycopeptides in hypothyroidism following thyroid hormone therapy.
    Tokoro T; Eto Y
    Eur J Pediatr; 1985 May; 144(1):84-6. PubMed ID: 3160592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and biochemical effects of long-term vitamin A administration to a patient with Hurler-Scheie compound.
    Wannmacher CM; Wajner M; Giugliani R; Costa MG; Giugliani ER; Castro JZ
    Braz J Med Biol Res; 1984; 17(1):43-7. PubMed ID: 6236861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary glycosaminoglycan excretion in urolithiasis.
    Harangi F; Györke Z; Melech B
    Arch Dis Child; 2000 Jan; 82(1):88. PubMed ID: 10755995
    [No Abstract]   [Full Text] [Related]  

  • 38. Urinary glycosaminoglycan (uGAG) excretion in healthy pediatric and adolescent population.
    Komosinska-Vassev K; Blat D; Olczyk P; Szeremeta A; Jura-Półtorak A; Winsz-Szczotka K; Klimek K; Olczyk K
    Clin Biochem; 2014 Sep; 47(13-14):1341-3. PubMed ID: 24956269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Is matrix theory still important today?].
    Börner RH; Schneider HJ
    Z Urol Nephrol; 1982 Jun; 75(6):463-8. PubMed ID: 6812310
    [No Abstract]   [Full Text] [Related]  

  • 40. Paired observations of sulphate/uronic acid ratios in glycosaminoglycans of human dermis and urine.
    Poulsen JH; Cramers MK
    Scand J Clin Lab Invest; 1982 Apr; 42(2):107-12. PubMed ID: 6813943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.